Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.
暂无分享,去创建一个
M. Dohopolski | R. Bhargava | D. Pradhan | S. Beriwal | J. Kelley | R. Edwards | A. Olawaiye | P. Sukumvanich | Z. Horne | J. Comerci | M. Courtney-Brooks | M. M. Bockmeier | J. Berger | S. Taylor | Rohit Bhargava | Robert P. Edwards | M. J. Dohopolski | Dinesh Pradhan | Joseph L. Kelley | Sarah Taylor
[1] H. Mackay,et al. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).
[2] P. Maguire,et al. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck. , 2017, International journal of radiation oncology, biology, physics.
[3] J. Pignon,et al. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] J. Debus,et al. Oral Scientific SessionsPrognostic Factors and Impact of HPV/p16ink4a Status on Survival in Vulvar Cancer Patients Treated with Radiation Therapy , 2017 .
[5] David Y. Zhang,et al. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome. , 2017, Human pathology.
[6] S. Regauer,et al. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy. , 2017, Gynecologic oncology.
[7] Jordan H. Garst,et al. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. , 2017, The Lancet. Oncology.
[8] Brian O'Sullivan,et al. Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[9] C. Chung,et al. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Ronald W. Jones,et al. The Natural History of Vulvar Intraepithelial Neoplasia, Differentiated Type: Evidence for Progression and Diagnostic Challenges , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[11] Q. Zhang,et al. Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129. , 2016, International journal of radiation oncology, biology, physics.
[12] P. Catalano,et al. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. , 2016, Gynecologic oncology.
[13] J. McAlpine,et al. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[14] F. Lucas,et al. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva , 2016, Journal of lower genital tract disease.
[15] E. Oliva,et al. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR) , 2015, The American journal of surgical pathology.
[16] N. Muñoz,et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. , 2013, European journal of cancer.
[17] T. Grob,et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] J. Ordi,et al. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? , 2011, Gynecologic oncology.
[19] A. Zee,et al. Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma , 2011, Modern Pathology.
[20] T. Enomoto,et al. Two Distinct Pathways to Development of Squamous Cell Carcinoma of the Vulva , 2010, Journal of skin cancer.
[21] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[22] H. Jacobsson,et al. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. , 2010, Gynecologic oncology.
[23] J. Wohlfahrt,et al. Risk factors for invasive squamous cell carcinoma of the vulva and vagina—Population‐based case–control study in Denmark , 2008, International journal of cancer.
[24] J. Manola,et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. , 2007, The New England journal of medicine.
[25] J. Zamecnik,et al. Human Papillomavirus (HPV) Profiles of Vulvar Lesions: Possible Implications for the Classification of Vulvar Squamous Cell Carcinoma Precursors and for the Efficacy of Prophylactic HPV Vaccination , 2007, The American journal of surgical pathology.
[26] R. Zeillinger,et al. p16INK4a Expression in Invasive Vulvar Squamous Cell Carcinoma , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[27] J. Pintos,et al. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. , 2004, Gynecologic oncology.
[28] L. Signorello,et al. Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables. , 1999, Gynecologic oncology.
[29] L. Brinton,et al. Heterogeneous etiology of squamous carcinoma of the vulva , 1996, Obstetrics and gynecology.
[30] B. Monk,et al. Prognostic significance of human papillomavirus DNA in vulvar carcinoma , 1995 .
[31] H. van Tinteren,et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. , 1994, Gynecologic oncology.